Can your GP prescribe Mounjaro for weight loss?

Mounjaro is a prescription-only medicine (POM): a prescriber must assess your suitability before any supply can be made.
GP prescribing through the NHS has been possible in England since April 2026, but only where the practice has opted in — availability is patchy.
NHS criteria are strict and phased; many people who meet the private licensed threshold do not yet qualify for NHS supply.
A GPhC-registered online pharmacy can offer a private prescription route with no referral and no waiting list, subject to clinical assessment.

Yes, a GP can prescribe Mounjaro — but whether yours will depends on NHS commissioning rules that are still rolling out across England, and on your practice's participation in the scheme. Since April 2026, GP practices in England have been able to prescribe tirzepatide under a new contract arrangement, though participation is voluntary. That means two patients in the same town can have very different experiences, and many people who are clinically suitable are still being told to wait. Mounjaro (tirzepatide) is a prescription-only medicine, so any route to treatment requires a formal clinical assessment by a qualified prescriber before anything is dispensed.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the official guidance says, and what it means for you

What NICE and NHS England actually authorised

NICE's appraisal of tirzepatide, published in December 2024 and updated in September 2025, recommended it for adults with a BMI of 35 or above plus at least one weight-related condition from a defined list: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes. The threshold drops by 2.5 kg/m² for people from certain ethnic backgrounds under UK guidance. That recommendation unlocked NHS prescribing in principle, but the rollout is phased deliberately, because demand is expected to outstrip supply for some time.

From 23 June 2026, Cohort 2 opened: people with a BMI of 35–39.9 and four or more of those conditions can now be referred. The first cohort (BMI 40-plus, four or more conditions) launched in June 2025. Each stage is designed to ensure the NHS can deliver the wraparound diet and activity support that the approval requires alongside the medicine itself.

NHS England's guidance on weight-management injections makes clear that meeting the criteria does not guarantee access, your GP practice still needs to be participating, and referral to wraparound support must be in place. That is what makes the picture so variable from one postcode to another.

When a GP can prescribe Mounjaro through the NHS today

From 1 April 2026, GP practices in England can prescribe Mounjaro under the 2026/27 QOF contract. Crucially, participation is optional. Some practices signed up immediately; others are still assessing capacity or waiting for their ICB to confirm local arrangements. So even if you meet the clinical criteria, your GP may tell you they are not yet offering this service.

If your BMI and qualifying conditions fit the current phase, the conversation with your GP is worth having. Bring the numbers: your current BMI, your diagnosed conditions, and any recent blood-pressure or HbA1c readings. A GP who is opted in can check whether you fall within the active cohort and refer you to the support programme your treatment must run alongside.

For people who are curious about where they stand before making that appointment, understanding exactly when a GP can prescribe Mounjaro under the NHS rollout gives a clear breakdown of each phase and its criteria. It is worth reading alongside whatever your practice tells you, because the phases are moving quickly.

The private prescription route: what is different

Private prescribing follows the licensed criteria in the medicine's SmPC rather than the NICE NHS thresholds. That means adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as prediabetes, hypertension or high cholesterol, can be assessed, and if you fall below the NHS thresholds it is still worth reading about how to get Mounjaro if you are not obese to understand what the private route requires. No GP referral is needed. The range of prescribers authorised to prescribe Mounjaro includes GPhC-registered Independent Prescribers working in regulated online pharmacies, not only GPs.

At nume, a named prescriber, not software, reviews every consultation the same day it arrives. If you submit your consultation before 12pm on a weekday, a GPhC-registered Independent Prescriber reads your answers that day and, if clinically suitable, your treatment is dispatched the same afternoon for free next-working-day delivery via DPD. The process includes photo-ID verification, live weight confirmation, and GP notification in line with GPhC guidance, so your own doctor is kept in the loop even when the prescription originates privately. You can explore how that works on our about page.

Cost is a genuine consideration with the private route. The price of tirzepatide at a private pharmacy reflects the fact that Eli Lilly raised its UK list price significantly from September 2025, reported market prices since then have ranged roughly £149 to £375 per month depending on the dose and provider. For a fuller picture of what drives that figure and what a legitimate prescription price should include, the Mounjaro price guide is worth reading before you compare providers.

Checking any prescriber or pharmacy before you proceed

Whoever prescribes Mounjaro for you, the supply must come through a pharmacy you can verify. The GPhC register lets you check any online pharmacy's registration in under a minute. The MHRA has warned repeatedly about counterfeit weight-loss pens sold through social media and unregistered sellers, fake pens have in some cases contained insulin rather than tirzepatide, with serious consequences for patients who used them without knowing. A seller offering these medicines without clinical assessment is a clear warning sign, regardless of how low the price looks.

If you are considering buying Mounjaro online and want to understand what a safe, regulated process looks like from start to finish, the guide to buying Mounjaro online covers what to check. And if the NHS route still feels like the right path for you, the NHS Mounjaro prescribing page goes into the phased criteria in more detail.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions